Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12625001373460) titled 'CHAPTER: Clonal Haematopoiesis assessment: prevention, treatment, and research' on Dec. 9.
Study Type: Observational
Study Design:
Purpose: Natural history
Duration: Longitudinal
Selection: Defined population
Timing: Prospective
Primary Sponsor: Australian National University
Condition:
Clonal Haematopoiesis (CH)
Clonal Haematopoiesis (CH)
Blood - Haematological diseases
Intervention:
After providing written informed consent, participants will be asked to:
Provide peripheral blood samples for research purposes at screening (where required), Week 0, and then either annually, or biennially, thereafter al...